» Articles » PMID: 32973209

Effect of Fasting and Feeding on Apolipoprotein A-I Kinetics in Preβ-HDL, α-HDL, and Triglyceride-rich Lipoproteins

Overview
Journal Sci Rep
Specialty Science
Date 2020 Sep 25
PMID 32973209
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

The aim of this study was to compare the kinetics of apolipoprotein (apo)A-I during fed and fasted states in humans, and to determine to what extent the intestine contributes to apoA-I production. A stable isotope study was conducted to determine the kinetics of apoA-I in preβ high-density lipoprotein (HDL) and α-HDL. Six healthy male subjects received a constant intravenous infusion of H-leucine for 14 h. Subjects in the fed group also received small hourly meals. Blood samples were collected hourly during tracer infusion and then daily for 4 days. Tracer enrichments were measured by mass spectrometry and then fitted to a compartmental model using asymptotic plateau of very-low-density lipoprotein (VLDL) apoB100 and triglyceride-rich lipoprotein (TRL) apoB48 as estimates of hepatic and intestinal precursor pools, respectively. The clearance rate of preβ-HDL-apoA-I was lower in fed individuals compared with fasted subjects (p < 0.05). No other differences in apoA-I production or clearance rates were observed between the groups. No significant correlation was observed between plasma apoC-III concentrations and apoA-I kinetic data. In contrast, HDL-apoC-III was inversely correlated with the conversion of α-HDL to preβ-HDL. Total apoA-I synthesis was not significantly increased in fed subjects. Hepatic production was not significantly different between the fed group (17.17 ± 2.75 mg/kg/day) and the fasted group (18.67 ± 1.69 mg/kg/day). Increase in intestinal apoA-I secretion in fed subjects was 2.20 ± 0.61 mg/kg/day. The HDL-apoA-I kinetics were similar in the fasted and fed groups, with 13% of the total apoA-I originating from the intestine with feeding.

Citing Articles

Role of circulating sphingolipids in lipid metabolism: Why dietary lipids matter.

Calzada C, Vors C, Penhoat A, Cheillan D, Michalski M Front Nutr. 2023; 9:1108098.

PMID: 36712523 PMC: 9874159. DOI: 10.3389/fnut.2022.1108098.


Intestinal lipid absorption and transport in type 2 diabetes.

Verges B Diabetologia. 2022; 65(10):1587-1600.

PMID: 35908083 DOI: 10.1007/s00125-022-05765-8.

References
1.
Hegele R, Boren J, Ginsberg H, Arca M, Averna M, Binder C . Rare dyslipidaemias, from phenotype to genotype to management: a European Atherosclerosis Society task force consensus statement. Lancet Diabetes Endocrinol. 2019; 8(1):50-67. DOI: 10.1016/S2213-8587(19)30264-5. View

2.
Rye K, Barter P . Formation and metabolism of prebeta-migrating, lipid-poor apolipoprotein A-I. Arterioscler Thromb Vasc Biol. 2003; 24(3):421-8. DOI: 10.1161/01.ATV.0000104029.74961.f5. View

3.
Cohn J, Wagner D, Cohn S, Millar J, Schaefer E . Measurement of very low density and low density lipoprotein apolipoprotein (Apo) B-100 and high density lipoprotein Apo A-I production in human subjects using deuterated leucine. Effect of fasting and feeding. J Clin Invest. 1990; 85(3):804-11. PMC: 296498. DOI: 10.1172/JCI114507. View

4.
Rye K, Clay M, Barter P . Remodelling of high density lipoproteins by plasma factors. Atherosclerosis. 1999; 145(2):227-38. DOI: 10.1016/s0021-9150(99)00150-1. View

5.
Danielsen E, Hansen G, Poulsen M . Apical secretion of apolipoproteins from enterocytes. J Cell Biol. 1993; 120(6):1347-56. PMC: 2119749. DOI: 10.1083/jcb.120.6.1347. View